Skip to main content

  • Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients <60 Years of Age

    • Posted: 10/01/2022
    • Author:

      Mohamed M. Gad, Islam Y. Elgendy, Anas M. Saad, Ahmed N. Mahmoud, Toshiaki Isogai, Johnny Chahine, Amer N. Kadri, Ravi Ghanta, Ernesto Jimenez, Samir R. Kapadia and Hani Jneid

    • 2022CRM

    Abstract

    Background

    Transcatheter aortic valve replacement (TAVR) is an alternative therapeutic modality to surgical aortic valve replacement (SAVR) in patients with severe aortic stenosis (AS). In the current analysis, we compare the characteristics and outcomes of AVR procedures in patients <60 years of age.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details